SUBSCRIBE
SUBSCRIBE
News   Drug Development

India’s Ranbaxy Laboratories Recalls Gabapentin Tablets in U.S.

November 16, 2007 | 
1 min read

MUMBAI, Nov 16 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) is recalling some gabapentin tablets in the United States, a spokesman said, confirming a report in the Economic Times on Friday.

Clinical research Postmarket research Asia
MORE ON THIS TOPIC
Gloved hand holding a vial of mpox vaccine
Vaccines
Bavarian Nordic’s Mpox Shot Shows Antibody Responses Wane After 6 to 12 Months: Study
October 4, 2024
 · 
2 min read
 · 
Tristan Manalac
U.S. and Chinese flags in concrete, broken in the middle
BIOSECURE Act
WuXi Mulls Sale of Some US, European Operations: FT
October 3, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
BMS’ Schizophrenia Approval, Pfizer’s Sudden Sickle Cell Withdrawal and Roche’s Pharma Day
October 2, 2024
 · 
1 min read
 · 
Heather McKenzie
3D illustration of human kidneys on a scientific background
Immunology and inflammation
Kezar Reports Four Patient Deaths in Mid-Stage Lupus Nephritis Study, Pauses Enrollment
October 1, 2024
 · 
2 min read
 · 
Tristan Manalac